Attitudes of pharmacists and nurses toward their responsibilities in the drug treatment process.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E R Kaczmarek.
Explore the source record for details and available documents.
Pharmacists' and nurses' attitudes toward pharmacist-nurse relations and pharmaceutical services were surveyed before and after the implementation of satellite pharmacies at a 600-bed teaching hospital. The same questionnaire was distributed two months before decentralization (phase 1) and nine months after decentralization was completed (phase 2). Sixty questions about the pharmacy services and the drug treatment process were to be answered using a seven-point, Likert-type scale. Overall response rates for the two phases were 62% and 45%, respectively. Pharmacists' satisfaction with all measured aspects of pharmaceutical services increased after decentralization of services; nurses' satisfaction increased for all measures except pharmacist-conducted medication histories. Pharmacists' satisfaction with the nursing department was greater after decentralized services were implemented. Most aspects of role conflict, one of four measured antecedents to interdepartmental conflict, improved subsequent to decentralization of services. Because of changes in personnel between the two phases of the study, the results may represent the opinions of different people, rather than actual changes in satisfaction. The attitudes of nurses and pharmacists toward overall distributive pharmaceutical services and toward certain aspects of interprofessional relations improved after pharmaceutical services were decentralized.
Explore the source record for details and available documents.
In order to measure pharmacists' perceptions about the PPis for estrogen and oral contraceptives, questionnaires were distributed to a random sample of 105 community pharmacists in a large midwestern city. Seventy completed questionnaires were returned, producing a response rate of 67 percent. A slight majority of the responding pharmacists indicated that pharmacists should be responsible for distribution of these PPIs but that physicians should be responsible for determining whether a patient should receive a PPI. The pharmacists indicated that patient information should be verbally communicated and accompanied by a written summary sheet and that patients neither read nor understand these PPIs. Although limited in size and geographic area, this study suggests that retail pharmacists have doubts about the current PPI program mandated by the Food and Drug administration.
Explore the source record for details and available documents.
In order to determine community pharmacists' compliance with FDA PPI regulations, five trained shoppers were sent with estrogen prescriptions to 45 pharmacies in a large Midwestern city. Only 42 percent of the prescriptions dispensed were accompanied by a PPI. Fifty-six percent of the prescriptions were dispensed without safety caps. In all cases where a correct PPI was received, a follow-up phone call was made to a pharmacist at the pharmacy to determine the accuracy of the response to a question about information in the PPI. Only 39 percent of the pharmacists were able to correctly answer the phone-in question.